The global pandemic made it even harder to be successful in pharma pricing. The whole situation will make a big impact on the budget and supply chain and product availability. The government response will always try to reduce Healthcare expenses and as consequence and pharmaceutical price controls will increase. This is when the value will be the new Pharma currency and we´ll see new innovative pricing models in the market.
perfect storm– but we think this situation will act as an
innovative pricing incubatorand Vistex is here to help.
In this webinar, we´ll analyze not only the current situation but also we’ll go through the new emerging pricing models that are arising. Which ones are Hype and which one’s Hope?
Watch this webinar now on-demand and learn more about:
- The current situation in the Pharma industry
- Emerging trends: Which ones can help us to move ahead and which ones will leave us behind?
- How to do a full-insight trend analysis
- How Vistex can support you
Business Development Manager for Life Sciences at Vistex EMEA
Alejandra Garitonandía is the Business Development Manager for Life Sciences at Vistex EMEA. She is specialized in revenue management for Pharma and has a background in medical and business educational studies. During her international career, she holds different positions in business and IT. Her specialization is where business processes meet the IT systems and how to support efficient end-to-end revenue management.